Vanda Pharmaceuticals Inc (VNDA)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -8.507 | -7.488 | 9.379 | 28.326 | 4.588 | 5.882 | 1.022 | 0.391 |
Return on Equity (%) | -13.626 | -11.851 | 12.393 | 33.671 | 5.401 | 6.92 | 1.216 | 0.468 |
Return on Invested Capital (%) | -6.005 | -11.985 | 11.603 | 37.522 | 5.96 | 8.75 | 0.653 | -3.481 |
Operating Margin (%) | -12.263 | -9.347 | 13.125 | 12.777 | 12.755 | 15.767 | 4.442 | 3.291 |
Net Profit Margin (%) | -12.334 | -9.43 | 13.053 | 50.862 | 9.404 | 12.339 | 2.467 | 1.302 |
Book Value Per Share | 2.352 | 2.344 | 4.781 | 7.244 | 7.869 | 8.673 | 8.957 | 7.362 |
Earnings Per Share | -0.409 | -0.346 | 0.48 | 2.158 | 0.425 | 0.593 | 0.111 | 0.044 |
Cash Per Share | 0.919 | 0.748 | 1.163 | 0.842 | 1.112 | 0.931 | 2.378 | 2.361 |
Working Capital Per Share | 2.815 | 2.214 | 4.69 | 5.502 | 6.256 | 7.225 | 7.535 | 6.001 |
Operating Profit Per Share | 2.778 | 3.304 | 3.316 | 3.811 | 4.123 | 4.373 | 4.074 | 3.107 |
EBIT Per Share | -0.407 | -0.343 | 0.483 | 0.542 | 0.577 | 0.758 | 0.199 | 0.11 |
EBITDA Per Share | -0.407 | -0.343 | 0.483 | 0.542 | 0.577 | 0.758 | 0.199 | 0.11 |
Free Cash Flow Per Share | -0.647 | -0.376 | 0.907 | 2.123 | 0.406 | 0.551 | 0.074 | -0.002 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 44M | 44.94M | 52.48M | 53.55M | 54.87M | 55.9M | 56.78M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 56.78M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 8.845 | N/A | N/A | N/A | -9.827 | N/A | N/A |
Net Profit Margin (%) | N/A | 5.203 | N/A | N/A | N/A | -8.735 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 281.63M |
Price to Earnings Ratio | 112.33 |
Price to Sales Ratio | 1.46 |
Price to Cash Ratio | 2.07 |
Price to Book Ratio | 0.52 |
Dividend Yield | - |
Shares Outstanding | 58.31M |
Average Volume (1 week) | 655.26k |
Average Volume (1 Month) | 701.27k |
52 Week Change | 20.15% |
52 Week High | 6.75 |
52 Week Low | 3.46 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.